Treprostinil Safety Experience/Exposure
Overall Experience 843 Subjects
PAH Trial Experience 743 Patients
Controlled Trials
Studies 03/04/05 496 Patients
Open Label Study 06
Direct Enrollment 208 Patients
Open-Label Study
Study 06 631 Patients
423 of 445 eligible (95%)
Acute Trials Studies 01/02 39 Patients
Treprostinil Exposure
679 Patients
Previous slide
Next slide
Back to first slide
View graphic version